Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander D Miras

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
The American Journal of Clinical Nutrition|July 28, 2012
Gastric bypass surgery for obesity decreases the reward value of a sweet-fat stimulus as assessed in a progressive ratio taskAlexander D Miras, Robert N Jackson, Sabrina N Jackson, et al.
Human Reproduction (Oxford, England)|March 11, 2026
Ovulatory Recovery following weight loss in women with polycystic ovary syndrome and obesity: a post hoc analysis of the BAMBINI randomised controlled trialSuhaniya N S Samarasinghe, Ali Abbara, Patricia M Ortega, et al.
BMC Cancer|April 17, 2015
Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin--a longitudinal experience from a prospectively collected database of 1108 patientsFlorian Seyfried, Burkhard H von Rahden, Alexander D Miras, et al.
The British Journal of Surgery|November 29, 2024
Role of obesity-management medications before and after metabolic bariatric surgery: a systematic reviewRicardo V Cohen, Ji Yeon Park, Gerhard Prager, et al.
Obesity Surgery|September 18, 2015
Gastric Bypass-Related Effects on Glucose Control, β Cell Function and Morphology in the Obese Zucker RatFlorian Seyfried, Alexander D Miras, Laura Rotzinger, et al.
Cytokine|August 1, 2018
Effects of visfatin on brown adipose tissue energy regulation using T37i cellsGeorgios K Dimitriadis, Raghu Adya, Bee K Tan, et al.
Diabetes Research and Clinical Practice|December 23, 2025
Combining glucagon-like peptide 1 analogues with sodium-glucose cotransporter 2 inhibitors to treat patients with type 1 diabetes, BMI > 25 kg/m<sup>2</sup>, and chronic kidney disease - A randomised, controlled pilot studyEbaa Al Ozairi, Etab Taghadom, Mohammad Irshad, et al.
BMC Nephrology|December 31, 2018
Measurement of glomerular filtration rate in patients undergoing obesity surgeryLing L Chuah, Alexander D Miras, Laura M Perry, et al.
Oncotarget|April 24, 2018
Chemerin induces endothelial cell inflammation: activation of nuclear factor-kappa beta and monocyte-endothelial adhesionGeorgios K Dimitriadis, Jaspreet Kaur, Raghu Adya, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 17, 2026
Diabetes management in people undergoing metabolic-bariatric surgery: A guideline from the Joint British Diabetes Societies for Inpatient Care (JBDS-IP) GroupJeffrey W Stephens, Ketan Dhatariya, Andrew J Beamish, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
The American Journal of Clinical Nutrition|July 28, 2012
Gastric bypass surgery for obesity decreases the reward value of a sweet-fat stimulus as assessed in a progressive ratio taskAlexander D Miras, Robert N Jackson, Sabrina N Jackson, et al.
Human Reproduction (Oxford, England)|March 11, 2026
Ovulatory Recovery following weight loss in women with polycystic ovary syndrome and obesity: a post hoc analysis of the BAMBINI randomised controlled trialSuhaniya N S Samarasinghe, Ali Abbara, Patricia M Ortega, et al.
BMC Cancer|April 17, 2015
Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin--a longitudinal experience from a prospectively collected database of 1108 patientsFlorian Seyfried, Burkhard H von Rahden, Alexander D Miras, et al.
The British Journal of Surgery|November 29, 2024
Role of obesity-management medications before and after metabolic bariatric surgery: a systematic reviewRicardo V Cohen, Ji Yeon Park, Gerhard Prager, et al.
Obesity Surgery|September 18, 2015
Gastric Bypass-Related Effects on Glucose Control, β Cell Function and Morphology in the Obese Zucker RatFlorian Seyfried, Alexander D Miras, Laura Rotzinger, et al.
Cytokine|August 1, 2018
Effects of visfatin on brown adipose tissue energy regulation using T37i cellsGeorgios K Dimitriadis, Raghu Adya, Bee K Tan, et al.
Diabetes Research and Clinical Practice|December 23, 2025
Combining glucagon-like peptide 1 analogues with sodium-glucose cotransporter 2 inhibitors to treat patients with type 1 diabetes, BMI > 25 kg/m<sup>2</sup>, and chronic kidney disease - A randomised, controlled pilot studyEbaa Al Ozairi, Etab Taghadom, Mohammad Irshad, et al.
BMC Nephrology|December 31, 2018
Measurement of glomerular filtration rate in patients undergoing obesity surgeryLing L Chuah, Alexander D Miras, Laura M Perry, et al.
Oncotarget|April 24, 2018
Chemerin induces endothelial cell inflammation: activation of nuclear factor-kappa beta and monocyte-endothelial adhesionGeorgios K Dimitriadis, Jaspreet Kaur, Raghu Adya, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 17, 2026
Diabetes management in people undergoing metabolic-bariatric surgery: A guideline from the Joint British Diabetes Societies for Inpatient Care (JBDS-IP) GroupJeffrey W Stephens, Ketan Dhatariya, Andrew J Beamish, et al.
Pageof 8